ORANO: Activity Preserved and Continued Deleveraging Despite the Health Crisis Order intake of €1.9 billion and no impact of the crisis on the backlog Revenue down by -2.5% (bps) compared to 2019 due to production stoppages and postponements of activities, in connection with the pandemic EBITDA of €931 million compared to €900 million in 2019 (rate up to 25.3% compared to 23.8% in 2019) Positive net cash flow and improved liquidity Net cash flow of +€144 million (compared to +€219 million in 2019) and maintenance of a coverage rate of 100% of end-of-lifecycle liabilities Net debt do...